Balchem (Balchem) Interest Expense : $-22.6 Mil (TTM As of Dec. 2023)

View and export this data going back to 1986. Start your Free Trial

What is Balchem Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Balchem's interest expense for the three months ended in Dec. 2023 was $ -5.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-22.6 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Balchem's Operating Income for the three months ended in Dec. 2023 was $ 38.3 Mil. Balchem's Interest Expense for the three months ended in Dec. 2023 was $ -5.3 Mil. Balchem's Interest Coverage for the quarter that ended in Dec. 2023 was 7.25. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Balchem Interest Expense Historical Data

The historical data trend for Balchem's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balchem Interest Expense Chart

Balchem Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-5.96

-4.44

-2.46

-10.27

-22.61

Balchem Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-5.12	-5.57	-5.16	-6.59	-5.29

Balchem Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-22.6 Mil.

Balchem (NAS:BCPC) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Balchem's Interest Expense for the three months ended in Dec. 2023 was $-5.3 Mil. Its Operating Income for the three months ended in Dec. 2023 was $38.3 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $326.1 Mil.

Balchem's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	38.335	/	-5.291
	=	7.25

The higher the ratio, the stronger the company's financial strength is.

Balchem (Balchem) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Balchem Corp (NAS:BCPC) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

BL9B:Germany BL9B:Germany

Address

5 Paragon Drive, Montvale, NJ, USA, 07645

Website

https://www.balchem.com

Balchem Corp is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia.

Executives

David B Fischer	director	425 WINTER ROAD, DELAWARE OH 43015
Olivier Rigaud	director	CORBION NV, PIET HEINKADE 127, AMSTERDAM P7 1019 GM
Monica Vicente	director	C/O FRESH DEL MONTE PRODUCE INC., P.O. BOX 149222, CORAL GABLES FL 33114
Michael Robert Sestrick	officer: Chief Technology Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Frederic Boned	officer: SVP/GM, Human Nutri. & Health	5 PARAGON DRIVE, MONTVALE NJ 07645
Van Gunsteren Job Leonard	officer: Vice President	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Hatsuki Miyata	officer: General Counsel and Secretary	5 PARAGON DRIVE, MONTVALE NJ 07645
Michael Bent Tignor	officer: Chief Human Resources Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Jonathan Harrison Griffin	officer: Vice President	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Martin Luther Reid	officer: Chief Supply Chain Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
William A. Backus	officer: Chief Accounting Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Kathleen B Fish	director	ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
James C Hyde	officer: Sr. Vice President	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Scott C Mason	officer: Vice President	C/O NOVAMERICAN STEEL INC, 1050 UNIVERSITY AVENUE, NORWOOD MA 02062
Joyce J. Lee	director	C/O ZOETIS INC., 100 CAMPUS DRIVE, FLORHAM PARK NJ 07940